Danxia
About:
Danxia develops biological blood products.
Website: http://www.danxia-biopharm.com/
Top Investors: GF Xinde Investment Management, ShenZhen GTJA Investment Group, Soochow Venture Capital, Ch-gemstone capital, Orient Minerva Asset
Description:
Danxia has the capacity to produce integrated machines. They offer forms of assistance to domestic producers while offering their clients premium products, technical assistance services.
Total Funding Amount:
13M CNY
Headquarters Location:
Guangzhou Shi, Guangdong, China
Founded Date:
2002-04-19
Founders:
Number of Employees:
101-250
Last Funding Date:
2016-12-22
IPO Status:
Private
Industries:
© 2025 bioDAO.ai